• Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism diagnosis and treatment. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2009 Feb. 79 p. [220 references]

Does not apply to this measure

This measure is used to assess the percentage of patients diagnosed with venous thromboembolism (VTE) who meet the criteria for low-molecular-weight heparin (LMWH) and for whom LMWH is used.

The priority aim addressed by this measure is to improve accurate diagnosis and treatment of venous thromboembolism (VTE).

Venous thromboembolism (VTE); low-molecular-weight heparin (LMWH)

Number of patients diagnosed with lower extremity venous thromboembolism (VTE) who meet the criteria for low-molecular-weight heparin (LMWH) (see the related "Denominator Inclusions/Exclusions" field in the Complete Summary)

Number of patients with a diagnosis of venous thromboembolism (VTE) who are treated with low-molecular-weight heparin (LMWH) (see the related "Numerator Inclusions/Exclusions" field in the Complete Summary)

Administrative data
Medical record

Percentage of patients diagnosed with venous thromboembolism (VTE) who meet the criteria for low-molecular-weight heparin (LMWH) and for whom low-molecular-weight heparin (LMWH) is used.

Institute for Clinical Systems Improvement

The following Minnesota health plans provide direct financial support: Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica, Metropolitan Health Plan, PreferredOne and UCare Minnesota. In-kind support is provided by the Institute for Clinical Systems Improvement's (ICSI) members.

Work Group Members: Bruce Burnett, MD (Work Group Leader) (Park Nicollet Health Services) (Internal Medicine); Mary Michener, MD (Winona Clinic) (Family Medicine); Denise Dupras, MD (Mayo Clinic) (Internal Medicine); Thomas Gabert, MD, MPH (Marshfield Clinic) (Internal Medicine); Seema Maddali, MD, MPH (Fairview Health Services) (Internal Medicine); Cindy Felty, NP (Mayo Clinic) (Nursing and Health Education); Peter Marshall, PharmD (HealthPartners Health Plan) (Pharmacy); Keith Harmon, MD (Park Nicollet Health Services) (Pulmonology); Mark Melin, MD (Park Nicollet Health Services) (Vascular Surgery); Penny Fredrickson (Institute for Clinical Systems Improvement) (Facilitator); Myounghee Hanson (Institute for Clinical Systems Improvement) (Facilitator)

ICSI has adopted a policy of transparency, disclosing potential conflict and competing interests of all individuals who participate in the development, revision and approval of ICSI documents (guidelines, order sets and protocols). This applies to all work groups (guidelines, order sets and protocols) and committees (Committee on Evidence-Based Practice, Cardiovascular Steering Committee, Women's Health Steering Committee, Preventive & Health Maintenance Steering Committee and Respiratory Steering Committee).

Participants must disclose any potential conflict and competing interests they or their dependents (spouse, dependent children, or others claimed as dependents) may have with any organization with commercial, proprietary, or political interests relevant to the topics covered by ICSI documents. Such disclosures will be shared with all individuals who prepare, review and approve ICSI documents.

No work group members have potential conflicts of interest to disclose.

Measure was not adapted from another source.

2003 Apr

2009 Feb

This is the current release of the measure.

This measure updates a previous version: Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007 Jun. 91 p.

• Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism diagnosis and treatment. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2009 Feb. 79 p. [220 references]

This NQMC summary was completed by ECRI on February 9, 2004. This NQMC summary was updated by ECRI Institute on July 27, 2004, July 20, 2005, May 1, 2006, October 8, 2007, and again on June 30, 2009.

This NQMC summary (abstracted Institute for Clinical Systems Improvement [ICSI] Measure) is based on the original measure, which is subject to the measure developer's copyright restrictions.

The abstracted ICSI Measures contained in this Web site may be downloaded by any individual or organization. If the abstracted ICSI Measures are downloaded by an individual, the individual may not distribute copies to third parties.

If the abstracted ICSI Measures are downloaded by an organization, copies may be distributed to the organization's employees but may not be distributed outside of the organization without the prior written consent of the Institute for Clinical Systems Improvement, Inc.

All other copyright rights in the abstracted ICSI Measures are reserved by the Institute for Clinical Systems Improvement, Inc. The Institute for Clinical Systems Improvement, Inc. assumes no liability for any adaptations or revisions or modifications made to the abstracts of the ICSI Measures.